On assay robustness: the importance of early determination and science-driven decision-making
Regulated bioanalysis in Japan: where do we come from and where are we going?
Current status of Vitamin D assays: are they reliable and sufficiently informative for clinical studies?
Micro-LC–MS/MS: the future of bioanalysis
Establishment of glycomic research center
Partnership formed between inVentiv Health and Bell Medical Solutions
Nuclea Biotechnologies forms alliance with Wilex, Inc. to advance personalized treatment for breast cancer sufferers
Covance continues investment in the Asia Pacific region
PRA secures grant to employ new graduates
Interview with Dr Bowsher
Bioanalysis Young Investigator: AWARD 2013
Anna Vallverdú Queralt
Domniki Fragou
Kalliope Panoutsopoulou
Jeanethe Anguizola
LC–MS and chemometrics for steroid biomarker profiles in view of the future diagnostics of diseases?
Rapid determination of hexapeptides by hydrophilic interaction LC–MS/MS for in vitro skin-penetration studies
Dual universal peptide approach to bioanalysis of human monoclonal antibody protein drug candidates in animal studies
Parallel artificial liquid membrane extraction: micro-scale liquid–liquid–liquid extraction in the 96-well format
The advantages of microflow LC–MS/MS compared with conventional HPLC–MS/MS for the analysis of methotrexate from human plasma
A simple LC–MS/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients
A critical review of microextraction by packed sorbent as a sample preparation approach in drug bioanalysis
Noninvasive analysis of volatile biomarkers in human emanations for health and early disease diagnosis
Acknowledgements